BREA, California (TheStreet) -- Danaher(DHR_) reached an agreement to buy Beckman Coulter(BEC_), a maker of biomedical testing equipment, for $83.50 a share in cash, or about $6.8 billion including assumed debt.
The purchase price is a 46% premium over Beckman Coulter's closing price of $57.09 on Dec. 9, 2010, before rumors of an acquisition first surfaced, the companies said in a statement Monday.
The transaction is expected to be completed in the first half of 2011.
Read more about Danaher Agreed to Buy Beckman Coulter for $6.8 Billion
The purchase price is a 46% premium over Beckman Coulter's closing price of $57.09 on Dec. 9, 2010, before rumors of an acquisition first surfaced, the companies said in a statement Monday.
The transaction is expected to be completed in the first half of 2011.
Read more about Danaher Agreed to Buy Beckman Coulter for $6.8 Billion
